TLPH

Companies
NASDAQ
Talphera Inc.
Health Care
Price Chart
Overview

About TLPH

Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

Market Cap
$16.5M
Volume
17.9K
Avg. Volume
18.7K
P/E Ratio
-0.51958764
Dividend Yield
0.00%
Employees
30.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Drug Manufacturers - Specialty & Generic
Risk & Correlation Analysis
Market Correlation
N/A
N/A
Volatility
N/A
Relative to market

Macro Factor Sensitivities

Interest Rates
High Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
High Sensitivity
Commodity Prices
High Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for TLPH.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, TLPH shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$16.5M
Volume17.9K
P/E Ratio-0.52
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 15, 2025
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how TLPH fits into your investment strategy and portfolio diversification.

Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025